This article covers the Inspection findings for possible Alzheimer’s drugs by Hoau-Yan Wang, an academic partner of Cassava Sciences. Science contacted Redica Systems to review the findings and get insights from our CEO, Michael de la Torre, and Senior Quality Expert, Jerry Chapman. Read the full article here.